Zobrazeno 1 - 10
of 221
pro vyhledávání: '"Ian R Crocker"'
Autor:
Jaymin Jhaveri, En Cheng, Sibo Tian, Zachary Buchwald, Mudit Chowdhary, Yuan Liu, Theresa W. Gillespie, Jeffrey J. Olson, Aidnag Z. Diaz, Alfredo Voloschin, Bree R. Eaton, Ian R. Crocker, Mark W. McDonald, Walter J. Curran, Kirtesh R. Patel
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Background: To investigate the impact of proton radiotherapy (PBT) on overall survival (OS) and evaluate PBT usage trends for patients with gliomas in the National Cancer Data Base (NCDB).Methods: Patients with a diagnosis of World Health Organizatio
Externí odkaz:
https://doaj.org/article/cf138603947d4cedb94a4c3bbd8c05fd
Autor:
Michael E, Scheurer, Renke, Zhou, Mark R, Gilbert, Melissa L, Bondy, Erik P, Sulman, Ying, Yuan, Yanhong, Liu, Elizabeth, Vera, Merideth M, Wendland, Emad F, Youssef, Volker W, Stieber, Ritsuko R, Komaki, John C, Flickinger, Lawrence C, Kenyon, H Ian, Robins, Grant K, Hunter, Ian R, Crocker, Samuel T, Chao, Stephanie L, Pugh, Terri S, Armstrong
Publikováno v:
Neuro-oncology advances. 4(1)
We sought to identify clinical and genetic predictors of temozolomide-related myelotoxicity among patients receiving therapy for glioblastoma.Patients (23% of patients developed myelotoxicity (Myelotoxicity during concurrent chemoradiation with temoz
Autor:
Ian R. Crocker, Walter J. Curran, Zachary S. Buchwald, Neil T. Pfister, Mudit Chowdhary, Shannon E. Kahn, Jeffrey J. Olson, D.G. Tanenbaum, Bree R. Eaton, Jaymin Jhaveri, Eduard Schreibmann, Mustafa Abugideiri, Hui-Kuo Shu, Jeffrey M. Switchenko, Roshan S. Prabhu, Kirtesh R. Patel
Publikováno v:
Practical Radiation Oncology. 10:36-43
Purpose Stereotactic radiosurgery (SRS) is increasingly used in the management of patients with resected brain metastases (rBMs). A significant complication of this therapy can be radiation necrosis (RN). Despite radiation therapy dose de-escalation
Autor:
Michael E Scheurer, Renke Zhou, Mark R Gilbert, Melissa L Bondy, Erik P Sulman, Ying Yuan, Yanhong Liu, Elizabeth Vera, Merideth M Wendland, Emad F Youssef, Volker W Stieber, Ritsuko R Komaki, John C Flickinger, Lawrence C Kenyon, H Ian Robins, Grant K Hunter, Ian R Crocker, Samuel T Chao, Stephanie L Pugh, Terri S Armstrong
Publikováno v:
Neuro-Oncology Advances. 4
Background We sought to identify clinical and genetic predictors of temozolomide-related myelotoxicity among patients receiving therapy for glioblastoma. Methods Patients (n = 591) receiving therapy on NRG Oncology/RTOG 0825 were included in the anal
Autor:
Kirtesh R. Patel, Justin Roper, Ian R. Crocker, Jaymin Jhaveri, Anees Dhabaan, Hui-Kuo Shu, Robert H. Press, Eric Elder, Matthew J. Ferris, Bree R. Eaton, Jeffrey M. Switchenko, Mudit Chowdhary, Walter J. Curran, Xinyan Zhang, Tiffany M. Morgan, Jeffrey J. Olson
Publikováno v:
Journal of Neurosurgery. 130:797-803
OBJECTIVEThe optimal margin size in postoperative stereotactic radiosurgery (SRS) for brain metastases is unknown. Herein, the authors investigated the effect of SRS planning target volume (PTV) margin on local recurrence and symptomatic radiation ne
Autor:
Grant K. Hunter, Mark R. Gilbert, H. Ian Robins, David Brachman, Ian R. Crocker, Jeffrey S. Wefel, Stephanie L. Pugh, Terri S. Armstrong, Merideth M Wendland, Kevin S. Roof, Minhee Won, Paul D. Brown, Minesh P. Mehta
Publikováno v:
Neuro Oncol
Background Results of NRG Oncology RTOG 0825 reported adding bevacizumab to standard chemoradiation did not significantly improve survival endpoints and resulted in greater decline in neurocognitive function (NCF) and patient-reported outcomes (PRO)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9919ba2d2e50c394c7a9df213e46a97d
https://europepmc.org/articles/PMC8661434/
https://europepmc.org/articles/PMC8661434/
Autor:
Ziyan Liu, Minhee Won, Edward G. Shaw, Andrea L. Salavaggione, David G. Johnson, Aline Paixão Becker, Ian R. Crocker, Minesh P. Mehta, Jessica Fleming, Arnab Chakravarti, Erica Hlavin Bell, Kenneth Aldape, Cynthia Timmers, Peixin Zhang, Dennis E. Bullard, Albert Murtha, Geoffrey R. Barger, Christopher J. Schultz, David Brachman, Grant K. Hunter, Mark R. Gilbert, Nadia Laack, Stanley Z. Gertler, Keith J. Stelzer, Jan C. Buckner, Joseph P. McElroy, Paul D. Brown
Publikováno v:
J Clin Oncol
PURPOSE NRG Oncology/RTOG 9802 (ClinicalTrials.gov Identifier: NCT00003375 ) is a practice-changing study for patients with WHO low-grade glioma (LGG, grade II), as it was the first to demonstrate a survival benefit of adjuvant chemoradiotherapy over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b12ab71274bee194a6b2919dfa8f74
https://europepmc.org/articles/PMC7527157/
https://europepmc.org/articles/PMC7527157/
Autor:
Debra Saxe, Michael R. Rossi, Zachary S. Buchwald, Jennifer Hauenstein, Hui-Kuo Shu, Jeffrey J. Olson, Carlos S. Moreno, Sibo Tian, Walter J. Curran, Stewart G. Neill, Geoffrey H. Smith, Jim Zhong, Jeffrey M. Switchenko, Ian R. Crocker, Roshan S. Prabhu, Robert H. Press
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Allele-specific copy number analysis of tumors (ASCAT) assesses copy number variations (CNV) while accounting for aberrant cell fraction and tumor ploidy. We evaluated if ASCAT-assessed CNV are associated with survival outcomes in 56 patients with WH
Autor:
Hans E. Grossniklaus, Pia R. Mendoza, Matthew J. Ferris, Mohammad K. Khan, H. Danish, Chris S. Bergstrom, Maria M. Choudhary, John H. Suh, Ian R. Crocker, Caroline Craven, Ehsan H. Balagamwala, Arun D. Singh, Thomas M. Aaberg, Kirtesh R. Patel, Jeffrey M. Switchenko
Publikováno v:
Melanoma Research. 28:120-125
PURPOSE: For treatment of choroidal melanoma, Palladium-103 ((103)Pd) and Ruthenium-106 ((106)Ru) plaque brachytherapy demonstrates reduced toxicity compared to the historical standard Iodine-125 ((125)I). No report has directly compared clinical out
Autor:
Walter J. Curran, Alfredo Voloschin, Jaymin Jhaveri, Hui-Kuo Shu, Yuan Liu, Ian R. Crocker, Bree R. Eaton, Mudit Chowdhary, Zachary S. Buchwald, Jeffrey J. Olson, Theresa W. Gillespie, Kirtesh R. Patel
Publikováno v:
Cancer. 124:1169-1178
BACKGROUND The addition of chemotherapy to adjuvant radiotherapy (chemotherapy and radiation therapy [CRT]) improves overall survival (OS) for patients with high-risk grade 2 gliomas; however, the impact of chemotherapy alone (CA) is unknown. This st